GO:0060039 pericardium development: Embryonic Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060039 pericardium development describes the progression of the pericardium, a double-walled sac enclosing the heart and the roots of the aorta, vena cava and pulmonary artery, from its formation to the mature structure.
• The pericardium arises during early cardiogenesis from mesodermal progenitors that also contribute to the epicardium and coronary vasculature.
• Epicardial-derived cells and the extracellular matrix (ECM) are central drivers of pericardial and cardiac wall maturation.
• Disruption of pericardium development is linked to congenital heart defects, pericardial effusion, constrictive pericarditis and abnormal coronary vessel formation.
• Key genes studied in this process include WT1, TBX18, TCF21, GATA4, NKX2-5, HAND2, BMP4, FGF2, VEGFA and others.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of candidate genes in pericardium development.
Description
GO:0060039 pericardium development is the biological process whose specific outcome is the progression of the pericardium over time, from its formation to the mature structure. The pericardium is a double-walled sac that contains the heart and the roots of the aorta, vena cava and the pulmonary artery. This term is essential for researchers studying cardiogenesis, congenital heart disease and pericardial pathology because the pericardium provides mechanical protection, immune surveillance and a niche for cardiac progenitor cells. Understanding pericardium development at the molecular level requires integrating embryology, genetics and cell biology, with model organisms and human pluripotent stem cell systems providing key insights. The process is tightly coordinated with epicardium formation, coronary vessel development and ECM remodeling, making it a hub for gene discovery in cardiovascular biology.
pericardium development At A Glance
| GO ID | GO:0060039 |
|---|---|
| GO term | pericardium development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Formation and maturation of the double-walled pericardial sac that encloses the heart and roots of the aorta, vena cava and pulmonary artery |
| Related processes | Epicardium development, coronary vessel development, ECM remodeling |
| Key cell types | Mesothelial cells, epicardial-derived cells, fibroblasts, vascular progenitors |
| Model organisms | Mouse, chick, zebrafish, Xenopus |
| Human relevance | Congenital heart defects, pericarditis, pericardial effusion, constrictive pericarditis |
What Is GO:0060039?
In our own words, GO:0060039 pericardium development encompasses all cellular and molecular events that build and mature the pericardium, the double-walled sac surrounding the heart and the roots of the great vessels. This includes specification of pericardial progenitor cells, formation of the pericardial cavity, differentiation of the serous and fibrous layers, and establishment of the pericardial fluid environment. The term is a biological process and is distinct from pericardium morphogenesis or epicardium development, although these processes are functionally intertwined.
Why Is pericardium development Important in Cell Biology?
Pericardium development is critically important because the pericardium is not a passive sac but an active participant in heart formation, providing mechanical constraints, paracrine signals and a reservoir of progenitor cells that contribute to the coronary vasculature and cardiac fibroblasts. Defects in this process can lead to congenital heart disease, pericardial effusion and constrictive pericarditis, which are significant causes of morbidity and mortality. Moreover, understanding pericardium development informs regenerative strategies, as epicardial-derived cells can be harnessed for cardiac repair.
• Provides mechanical protection and lubrication for the heart, preventing friction during contraction.
• Serves as a source of epicardial progenitor cells that contribute to coronary vessels and cardiac fibroblasts.
• Regulates heart tube looping and chamber formation through ECM and signaling molecules.
• Disruption is associated with congenital heart defects such as ventricular septal defects and outflow tract anomalies.
• Pericardial inflammation (pericarditis) and effusion are common clinical problems linked to developmental and acquired abnormalities.
• Constrictive pericarditis can result from abnormal pericardial fibrosis, highlighting the need to understand developmental pathways.
• The pericardium is used as a biomaterial in surgical and dental applications, underscoring its structural importance.
• Imaging of the pericardium is essential for diagnosis of pericardial diseases, requiring knowledge of normal development.
• Percutaneous access techniques often traverse the pericardium, making its anatomy and development clinically relevant.
• ECM components deposited during pericardium development influence cardiac repair and regeneration.
What Happens During pericardium development?
Specification of pericardial progenitors
In simple terms: Early embryonic cells are told to become the cells that will form the pericardium.
During gastrulation and early cardiogenesis, mesodermal progenitors in the lateral plate mesoderm are specified toward a cardiogenic fate that includes pericardial and epicardial lineages. Signaling from BMP, FGF and WNT pathways patterns this mesoderm, and transcription factors such as NKX2-5, GATA4 and TBX18 are activated in progenitor populations. These progenitors migrate to the anterior lateral plate and form the cardiogenic crescent, which later gives rise to the heart tube and the pericardial mesothelium.
Formation of the pericardial cavity
In simple terms: A fluid-filled space forms around the developing heart tube.
As the heart tube elongates and loops, the surrounding mesoderm splits to create the pericardial cavity, a coelomic space lined by mesothelial cells. This cavity allows the heart to move and grow without friction. The splanchnic mesoderm contributes to the visceral pericardium (epicardium), while the somatic mesoderm forms the parietal pericardium. Proper cavity formation depends on ECM remodeling and cell death that sculpt the coelomic lining.
Differentiation of epicardium and fibrous pericardium
In simple terms: The inner and outer layers of the pericardium mature into distinct tissues.
The epicardium, which is the visceral layer of the pericardium, arises from the proepicardial organ and spreads over the heart surface. Epicardial cells undergo epithelial-to-mesenchymal transition (EMT) to generate epicardium-derived cells (EPDCs) that migrate into the myocardium and form fibroblasts, smooth muscle cells and endothelial cells of coronary vessels. The parietal pericardium differentiates into a fibrous layer rich in collagen and elastin, providing tensile strength. This differentiation is regulated by WT1, TBX18, TCF21 and retinoic acid signaling.
ECM deposition and maturation
In simple terms: The pericardium builds a strong scaffold of proteins that give it structure.
The extracellular matrix (ECM) of the pericardium is composed of collagens, elastin, fibronectin, laminin and proteoglycans, which are secreted by mesothelial and fibroblast-like cells. ECM remodeling enzymes such as matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) regulate the balance between synthesis and degradation. This ECM not only provides mechanical support but also sequesters growth factors like FGF2 and VEGFA, influencing coronary vessel development. Disruption of ECM components leads to pericardial defects and abnormal heart looping.
Integration with coronary vessel development
In simple terms: The pericardium helps build the blood vessels that feed the heart.
EPDCs derived from the epicardium migrate into the myocardium and differentiate into endothelial and smooth muscle cells that form the coronary arteries and veins. Signaling through VEGFA, FGF2, and Notch pathways guides this process. The pericardial cavity also serves as a conduit for progenitor cells that contribute to the coronary vasculature. Defects in this integration can lead to coronary anomalies and myocardial ischemia.
Key Genes Involved in GO:0060039 pericardium development
The following genes have been experimentally implicated in pericardium development, epicardium formation and related cardiovascular processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| WT1 | Transcription factor essential for epicardium and pericardium development; marker of epicardial progenitors | Knockout causes epicardial defects and coronary anomalies; used to study EMT and progenitor specification |
| TBX18 | Transcription factor required for proepicardial organ formation and epicardial differentiation | Mutations linked to congenital heart defects; model for epicardial lineage tracing |
| TCF21 | Transcription factor regulating epicardial EMT and fibroblast differentiation | Knockout leads to impaired coronary vessel development; target for cardiac fibrosis research |
| GATA4 | Zinc finger transcription factor critical for heart tube formation and pericardial mesoderm patterning | Mutations associated with congenital heart disease; used in cardiac differentiation protocols |
| NKX2-5 | Homeobox transcription factor specifying cardiogenic mesoderm including pericardial progenitors | Key marker for cardiac progenitors; knockout models show pericardial and heart defects |
| HAND2 | Basic helix-loop-helix transcription factor involved in heart morphogenesis and pericardial mesenchyme | Regulates ECM and signaling; knockout causes cardiac and pericardial abnormalities |
| BMP4 | Secreted growth factor that patterns lateral plate mesoderm and pericardial progenitors | Exogenous BMP4 used to direct stem cell differentiation; knockout affects heart and pericardium |
| FGF2 | Fibroblast growth factor promoting epicardial cell proliferation and ECM deposition | Used in culture to expand epicardial cells; modulates coronary vessel growth |
| VEGFA | Vascular endothelial growth factor driving coronary angiogenesis from epicardial-derived cells | Knockout causes coronary vessel defects; target for angiogenic therapies |
| WT1 | See above | See above |
| TBX5 | T-box transcription factor involved in heart and pericardial development | Mutations cause Holt-Oram syndrome; model for gene regulatory networks |
| MEF2C | Transcription factor regulating myocardial and epicardial gene expression | Knockout leads to cardiac looping defects; used in cardiac reprogramming |
| SNAI1 | Induces EMT in epicardial cells during coronary vessel formation | Overexpression promotes fibrosis; knockout impairs EPDC migration |
| COL1A1 | Major collagen component of pericardial ECM | Mutations cause connective tissue disorders; target for ECM remodeling studies |
| ELN | Elastin provides elasticity to the pericardium | Defects linked to supravalvular aortic stenosis; model for ECM assembly |
| MMP2 | Matrix metalloproteinase degrading ECM during pericardial remodeling | Knockout affects heart development; used to study ECM turnover |
| TIMP1 | Inhibitor of MMPs regulating ECM balance in pericardium | Overexpression causes fibrosis; target for anti-fibrotic strategies |
| RARB | Retinoic acid receptor mediating epicardial differentiation | Knockout causes pericardial defects; used to study retinoid signaling |
How Is pericardium development Regulated?
Pericardium development is regulated by a network of signaling pathways including BMP, FGF, WNT, retinoic acid and Notch, which control progenitor specification, EMT and ECM remodeling. Transcription factors such as WT1, TBX18, TCF21 and GATA4 act as master regulators of epicardial and pericardial gene expression. ECM stiffness and composition feedback on cell behavior through integrin signaling, modulating proliferation and differentiation. Additionally, hypoxia and metabolic cues influence epicardial cell fate, linking developmental regulation to oxygen availability.
pericardium development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WT1 | Epicardial defects, coronary anomalies, Wilms tumor | Knockout mouse, epicardial-specific Cre lines |
| TBX18 | Congenital heart defects, epicardial dysfunction | Knockout and conditional knockout mice |
| GATA4 | Ventricular septal defects, tetralogy of Fallot | Patient iPSC-derived cardiomyocytes, knock-in mice |
| VEGFA | Coronary artery anomalies, angiogenesis defects | Inducible knockout, overexpression in epicardium |
| COL1A1 | Ehlers-Danlos syndrome, pericardial fragility | Knock-in mouse models, ECM remodeling assays |
Congenital heart defects and pericardial anomalies
Disruptions in pericardium development are associated with congenital heart defects such as ventricular septal defects, outflow tract anomalies and coronary artery anomalies. Mutations in genes like GATA4, NKX2-5 and TBX5 cause syndromes that include pericardial and epicardial malformations. Animal models with knockout of WT1 or TBX18 exhibit defective epicardium and coronary vessels, highlighting the developmental origin of these defects.
Pericarditis and pericardial effusion
Acute pericarditis is a common clinical condition often triggered by viral infections, autoimmune diseases or myocardial infarction, and it can lead to pericardial effusion. Although not directly a developmental disorder, understanding the developmental biology of the pericardium informs the response to injury and inflammation. Imaging techniques are crucial for diagnosis and monitoring of pericardial diseases.
Constrictive pericarditis and fibrosis
Constrictive pericarditis results from fibrotic thickening and loss of elasticity of the pericardium, impairing diastolic filling. Developmental pathways such as TGF-beta and ECM remodeling are reactivated in this condition, making developmental genes potential therapeutic targets. Research into ECM regulation during development may yield insights into anti-fibrotic therapies.
Coronary vessel anomalies
Defective epicardial-derived cell migration and differentiation can lead to coronary vessel anomalies, including hypoplastic coronary arteries and fistulas. Genes such as VEGFA and FGF2 are critical for coronary angiogenesis, and their dysregulation is linked to ischemic heart disease. Studying pericardium development helps elucidate the origins of these vascular defects.
From pericardium development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate pericardial progenitor specification? | CRISPR knockout in mouse embryonic stem cells or zebrafish |
| What is the role of a point mutation in gene Y in epicardial EMT? | CRISPR point-mutation knock-in in human iPSCs |
| How does a disease-associated variant affect pericardial ECM? | Knock-in mouse model with conditional expression |
| Where is protein Z localized during pericardium development? | Tagged knock-in (e.g., GFP) in mouse or chick embryos |
| Can overexpression of gene W rescue pericardial defects? | Transgenic overexpression in zebrafish or mouse |
| What is the transcriptomic profile of epicardial-derived cells? | Single-cell RNA-seq of sorted EPDCs from reporter mice |
How to Study the pericardium development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptomic profiles of individual cells | Identify epicardial and pericardial cell subtypes |
| Lineage tracing (Cre-lox) | Cell fate and migration | Trace EPDC contribution to coronary vessels |
| Confocal microscopy | Protein localization and tissue architecture | Visualize pericardial layers and ECM |
| Proteomics (LC-MS/MS) | Protein composition and modifications | Characterize pericardial ECM |
| ATAC-seq | Chromatin accessibility | Identify regulatory elements in epicardial differentiation |
| Zebrafish knockdown | Gene function in vivo | Rapid screening of pericardial genes |
| Mouse conditional knockout | Tissue-specific gene function | Study role of WT1 in epicardium |
| iPSC differentiation | Human cell model of pericardium | Model congenital heart defects |
Lineage tracing and imaging
Lineage tracing using Cre-lox systems in mice (e.g., WT1-Cre, TBX18-Cre) allows visualization of pericardial and epicardial cell descendants. Confocal and light-sheet microscopy of fluorescent reporters reveal cell migration and differentiation in real time. These methods are essential for understanding the spatiotemporal dynamics of pericardium development.
Transcriptomics and single-cell analysis
RNA-seq and single-cell RNA-seq of developing hearts and epicardial cells identify gene expression programs and cell heterogeneity. These approaches have uncovered novel markers and regulatory networks in pericardium development. Integration with ATAC-seq reveals chromatin accessibility changes during differentiation.
Proteomics and ECM analysis
Mass spectrometry-based proteomics of pericardial tissue identifies ECM components and their post-translational modifications. Decellularized pericardial matrices can be analyzed to understand composition and mechanical properties. These methods link molecular changes to tissue-level function.
Functional assays in model organisms
Zebrafish and chick embryos are amenable to gene knockdown and overexpression via morpholinos or electroporation, enabling rapid functional testing. Mouse genetics remains the gold standard for causal studies, with conditional knockouts and knock-ins. These models allow assessment of pericardial defects, heart looping and coronary vessel formation.
How CRISPR Can Be Used to Study GO:0060039 pericardium development
Knockout
CRISPR-Cas9 knockout of candidate genes in mouse embryos or human iPSCs can reveal essential roles in pericardium development. For example, knockout of WT1 in mice results in epicardial defects and coronary anomalies, demonstrating causality. Knockout screens in zebrafish can identify novel regulators of pericardial formation.
Point Mutation
Introducing precise point mutations via CRISPR base editing or homology-directed repair allows modeling of human variants associated with congenital heart defects. For instance, a point mutation in GATA4 identified in patients can be knocked into iPSCs to assess its impact on epicardial differentiation. This approach distinguishes pathogenic variants from benign polymorphisms.
Knock-in
Knock-in of reporter genes (e.g., GFP, mCherry) or epitope tags into endogenous loci enables visualization and purification of pericardial cells. Knock-in of Cre recombinase under the control of WT1 or TBX18 promoters facilitates lineage tracing. These models are invaluable for studying cell fate and protein localization.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can test gain-of-function effects of genes like VEGFA or FGF2 on pericardium development. Overexpression of ECM components such as COL1A1 can model fibrotic pericarditis. These approaches complement loss-of-function studies to establish sufficiency.
How EDITGENE Supports pericardium development Research
Researchers studying pericardium development-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal investigations, from knockout to precise point mutations and overexpression, tailored to cardiovascular research.
Contact EDITGENE today to design your custom CRISPR model for pericardium development research.
Frequently Asked Questions About pericardium development
What is GO:0060039 pericardium development?
GO:0060039 is a Gene Ontology biological process term describing the progression of the pericardium, the double-walled sac around the heart and great vessels, from formation to mature structure.
What genes are involved in pericardium development?
Key genes include WT1, TBX18, TCF21, GATA4, NKX2-5, HAND2, BMP4, FGF2, VEGFA and ECM components like COL1A1 and ELN.
Why is pericardium development important?
It is crucial for heart protection, coronary vessel formation and cardiac function; defects lead to congenital heart disease and pericardial pathologies.
What diseases are linked to abnormal pericardium development?
Congenital heart defects, pericarditis, pericardial effusion, constrictive pericarditis and coronary anomalies.
How can CRISPR be used to study pericardium development?
CRISPR knockout, point mutation, knock-in and overexpression in model organisms and iPSCs allow causal testing of candidate genes.
What model organisms are used to study pericardium development?
Mouse, chick, zebrafish and Xenopus are common, along with human iPSC-derived epicardial cells.
What is the role of the epicardium in pericardium development?
The epicardium is the visceral layer of the pericardium and a source of progenitors for coronary vessels and cardiac fibroblasts.
How is the pericardium imaged clinically?
Radiologic techniques including echocardiography, CT and MRI are used to assess pericardial anatomy and pathology.
What is the function of the pericardial fluid?
It lubricates the heart, reducing friction during contraction, and provides a medium for immune surveillance.
Can pericardium development be studied in vitro?
Yes, human iPSCs can be differentiated into epicardial-like cells that model key aspects of pericardium development.
Conclusion
GO:0060039 pericardium development is a fundamental biological process that integrates cardiogenesis, ECM biology and progenitor cell differentiation. Understanding its molecular regulation provides insights into congenital heart disease, pericardial pathologies and regenerative medicine. CRISPR-based models and advanced omics technologies are powerful tools to dissect the genetic networks controlling this process, and EDITGENE offers comprehensive services to support such research.
References
- 1. Buijtendijk MFJ et al.. 2020. Development of the human heart.. Am J Med Genet C Semin Med Genet 184(1):7-22 PMID: 32048790
- 2. Lazarou E et al.. 2022. Acute Pericarditis: Update.. Curr Cardiol Rep 24(8):905-913 PMID: 35595949
- 3. Kopsa W et al.. 1997. [Pericardium--radiologic diagnosis].. Radiologe 37(5):378-87 PMID: 9312781
- 4. Klein-Júnior CA et al.. 2019. Development and evaluation of calcium hydroxide-coated, pericardium-based biomembranes for direct pulp capping.. J Investig Clin Dent 10(1):e12380 PMID: 30525301
- 5. Hale Z et al.. 2020. Techniques for Percutaneous Access.. Card Electrophysiol Clin 12(3):271-280 PMID: 32771182
- 6. Derrick CJ et al.. 2021. The ECM as a driver of heart development and repair.. Development 148(5) PMID: 33674261
- 7. Quijada P et al.. 2020. The Role of the Epicardium During Heart Development and Repair.. Circ Res 126(3):377-394 PMID: 31999538
- 8. Reese DE et al.. 2002. Development of the coronary vessel system.. Circ Res 91(9):761-8 PMID: 12411389
